|
SAE Media Group announced its 14th Annual RNA Therapeutics Conference which will be taking place at Copthorne Tara Hotel, Scarsdale Place, Kensington, London, on 8-9 February 2023, to investigate the next generation of genetic medicine through RNA-based therapies.
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.
In 2023, we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. We will also explore the latest trends in novel RNA therapies, including developments in AI modelling and small molecule modulation of RNA. Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more.
Don't miss this opportunity to network with the pharma and biotech community of global experts in the UK and Europe; the two-day agenda offers you peer-to-peer networking with Directors of novel RNA therapies, CEOs, Senior and expert scientists, chief medical officers, senior vice presidents and many more.
The two days Conference is designed for attending the pharma and biotech directors, managers and heads of departments of RNA; genetic medicine; oligonucleotide discovery; RNA discovery; new modalities; RNA biology; RNA formulation and delivery; targeted delivery; clinical development; pre-clinical development; oligonucleotide chemistry; drug discovery; target discovery; medicinal chemistry; RNA development; RNA vaccines and RNA biochemistry.
The event should be benefited to explore how mRNA is leading the way in the genetic medicine space as the next generation of novel drug modalities; to investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics; to enhance the knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH; to engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases.
|